Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Oct 28, 2025 (12 months ago)

Agebox iKids-Growth

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren

Cause type: Chemical / undeclared

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines. All chemical / undeclared recalls.

What was recalled

Agebox iKids-Growth (Night Formula), 60-count bottles, Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA, UPC 850065597027

Recalling firm
Agebox
Origin
DE, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0345-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Agebox

All 2025 recalls

Other chemical / undeclared recalls from 2025

All chemical / undeclared recalls
Class I · High risk

SILINTAN 25/pills

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Ongoing Chemical / undeclared ANTHONY TRINH, 123Herbals LLC D-0388-2026
Class I · High risk

Mojo Max Fusion XXX

Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).

Ongoing Chemical / undeclared Mohamed Hagar D-0396-2026